New data from CombiMatrix study support follow-up diagnostic testing
CombiMatrix announces data supporting the value of follow-up diagnostic testing to confirm or rule out positive results for common chromosomal aneuploidies and microdeletion syndromes detected by non-invasive prenatal testing. October 09, 2015